Kawasaki Ninja ZX-10R Price starts at Rs. 19.78 Lakh which is Rs. 18.15 Lakh costlier than base model of Hero XPulse 210 priced at Rs. 1.63 Lakh. The claimed mileage of Hero XPuls ...
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price ...
Compare Honda CB300R vs Kawasaki Ninja ZX-10R - Compare Honda CB300R with Kawasaki Ninja ZX-10R by price, specifications, features, mileage, engine performance, colours, images, etc at ZigWheels.
Air India is reportedly launching the controversial new policy in May Satyabrata Tripathy/Hindustan Times via Getty Air India has reportedly launched a new policy where cabin crew's pay could be ...
Repeating the same meals and keeping calorie intake steady produced more weight loss than eating a more varied diet among individuals living with overweight or obesity, a short-term trial showed.
"With the recent introduction of multiple generic variants of GLP-1-based weight loss drugs in the Indian market, concerns have emerged regarding their on-demand availability through retail pharmacies ...
https://www.thehindubusinessline.com/news/national/indias-drug-regulatory-authority-steps-up-surveillance-on-generic-glp-1-drugs/article70778406.ece Copy With generic ...
Affordable weight-loss jabs drive partnerships in nutrition products. Semaglutide generics lower costs, prompting growth in the obesity market. Companies pivoting to high-protein and functional foods ...
Just when the weight-loss party was kicking into high gear, the drug regulator has made an entry. The Drugs Controller General of India (DCGI) has asked states to ensure that endocrinologists - ...
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
With India primed for newer and cheaper GLP-1 drugs, with some already having hit the market – thanks to the expiry of the patent on semaglutide, the molecule behind Danish drugmaker Novo Nordisk’s ...
AI Quick Read MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy’s, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results